Among patients with previous sinus surgery for chronic rhinosinusitis with nasal polyps, the number of past surgeries did not ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

EMA accepts for review GSK’s application to expand use of Nucala for COPD treatment: London, UK Wednesday, March 26, 2025, 11:00 Hrs [IST] GSK plc announced that the European Me ...

The EMA has agreed to review GSK’s application to expand Nucala’s use as an add-on maintenance for individuals with COPD.

The European Medicines Agency accepts GSK's regulatory filing for expanded use of Nucala to treat COPD for review.

GSK (GSK) plc announced that the European Medicines Agency has accepted for review its application to expand the use of Nucala, a monoclonal ...

GSK said on Monday that the European Medicines Agency has accepted its application to expand the use of ‘Nucala’, or ...

The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

(Alliance News) - London's FTSE 100 is called to open higher on Monday, ahead of a slew of flash composite readings later in the day, and following the announcement of UK plans to cut government Civil ...

London open The FTSE 100 is expected to open 28 points higher on Monday, having closed down 0.63% on Friday at 8,646.79.

(Alliance News) - GSK PLC on Monday said it has had an application to expand the use of mepolizumab for the treatment of chronic obstructive pulmonary disease accepted for review by the European ...

Remission persisted through 104 weeks for most patients with eosinophilic granulomatosis with polyangiitis who used ...